Adam Mcananey Sells 9,092 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 9,092 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $285,943.40. Following the sale, the insider directly owned 209,004 shares of the company’s stock, valued at $6,573,175.80. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Down 4.1%

OSCR stock opened at $31.64 on Thursday. The firm has a market capitalization of $9.77 billion, a PE ratio of 22.60, a P/E/G ratio of 0.68 and a beta of 2.37. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.55. The stock’s 50 day moving average is $30.58 and its 200-day moving average is $23.14.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same period in the prior year, the firm posted ($0.89) EPS. Oscar Health’s quarterly revenue was up 70.4% compared to the same quarter last year. Sell-side analysts expect that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Oscar Health News Summary

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: A recent outlook article argues that Oscar Health’s future remains bright, supported by its technology-driven insurance platform, expanding membership opportunities and potential for continued earnings growth. The future looks bright for Oscar Health stock
• Positive Sentiment: The company’s latest quarterly results were substantially better than expected: earnings per share came in at $1.10 versus the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion. Analysts expect full-year EPS of approximately $1.54.
• Positive Sentiment: Institutional ownership remains high at approximately 75.7%, and several funds increased their Oscar Health holdings during the second quarter. Analyst sentiment has also improved in some cases, including a Zacks Research upgrade to “strong buy.”
• Neutral Sentiment: Oscar Health’s chief accounting officer Victoria Baltrus sold 958 shares for $30,129 under a pre-arranged Rule 10b5-1 plan. The filing said the sale covered tax withholding tied to vested equity awards; she retained 213,631 shares. Oscar Health CAO stock sale
• Neutral Sentiment: Director Mario Schlosser, CFO Richard Blackley, Adam Mcananey and Janet Liang also reported stock sales totaling roughly $2.5 million. Each transaction was conducted under a 10b5-1 plan and attributed to tax obligations, while all sellers retained sizable positions.
• Negative Sentiment: The cluster of insider selling may nevertheless weigh on sentiment, particularly because the transactions occurred near OSCR’s 52-week high. The stock’s average analyst rating remains “hold,” with a consensus price target of $26.22, below recent trading levels.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on OSCR. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a report on Friday, August 7th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Weiss Ratings raised Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $26.22.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new position in Oscar Health during the first quarter valued at $30,000. Fifth Third Bancorp increased its position in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares during the last quarter. CoreCap Advisors LLC raised its stake in shares of Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares during the period. Finally, Quarry LP raised its stake in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.